Cholesterol and the Amyloid Precursor Protein

胆固醇和淀粉样前体蛋白

基本信息

  • 批准号:
    8839797
  • 负责人:
  • 金额:
    $ 29.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-05-01 至 2016-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The amyloidogenic pathway is widely believed to be closely linked to most forms of Alzheimer's disease. In this pathway the full length amyloid precursor protein (APP) is cleaved by ß-secretase to release a 99 residue transmembrane C-terminal domain known as "C99". C99 is then cleaved by γ-secretase to release the amyloid-ß (Aß) polypeptides. There is a considerable body of data that elevated cholesterol in neuronal membranes promotes the amyloidogenic pathway, but there has not been a mechanistic explanation. In our recent work we have shown that C99 forms a specific 1:1 complex with cholesterol, with a dissociation constant well within the physiological concentration range of cholesterol in mammalian membranes. This observation, combined with a large body of literature evidence that the ß- and γ-secretases tend to be associated with cholesterol-rich membrane domains often referred to as "lipid rafts", suggests a compelling hypothesis for how cholesterol promotes amyloidogenesis. We hypothesize that formation of a complex between cholesterol and C99 (or full length APP) results in enhanced partitioning of C99/APP to lipid rafts, where ß- and γ-secretase reside. This enhances the rate of amyloid-ß production relative to conditions in which C99/APP is not complexed with cholesterol and the protein resides in bulk membranes. Aims are: Aim 1. Determine the structure of the C99/cholesterol complex in both bulk membranes and in "lipid rafts". This aim will provide the structural basis for molecular recognition of cholesterol by C99 and will also provide the first ever comparison of the structure of a membrane protein under model membrane conditions that mimic lipid rafts versus bulk membranes. Aim 2. Elucidate the structural determinants in cholesterol that drive its association with C99. This will involve binding studies between C99 and a variety of cholesterol analogs/metabolites and will further illuminate the basis for molecular recognition between C99 and cholesterol. It will also provide a starting point for developing compounds that mimic cholesterol but that bind even more avidly to C99. Moreover, we will test the possibility that cholesterol analogs known to be "raft-phobic" can compete effectively with cholesterol for binding to C99. Aim 3. Determine whether binding of cholesterol to C99 and APP increases partitioning of these proteins into lipid rafts. Both giant unilamellar vesicles and cell-derived vesicles will be employed. These studies will test the hypothesis that association of cholesterol with the C99 and APP drives partitioning of these protein into rafts. Moreover, using selected compounds from Aim 2 that compete effectively with cholesterol but that have no avidity for rafts, we will also test whether raft association of C99/APP can be suppressed.
描述(申请人提供):淀粉样变通路被广泛认为与大多数形式的阿尔茨海默病密切相关。在这个途径中,全长的淀粉样前体蛋白(APP)被ç-分泌酶切割,释放出一个99个残基的跨膜C-末端结构域,称为“C99”。然后,C99被γ-分泌酶切割,释放淀粉样蛋白多肽。有相当多的数据表明,神经细胞膜中胆固醇的升高促进了淀粉样变的发生,但还没有一个机制上的解释。在我们最近的工作中,我们已经证明了C99与胆固醇形成了1:1的特异性络合物,其解离常数在哺乳动物细胞膜中胆固醇的生理浓度范围内。这一观察结果与大量文献证据相结合,表明ç-和γ-分泌酶往往与富含胆固醇的膜域相关,通常被称为“脂筏”,这为胆固醇如何促进淀粉样蛋白的发生提出了一个令人信服的假说。我们假设胆固醇和C99(或全长APP)之间形成的复合体导致了C99/APP到脂筏的增强分配,其中?和γ-分泌酶驻留。与C99/APP不与胆固醇络合且蛋白质驻留在大块膜中的条件相比,这提高了淀粉样蛋白的产生速度。目的:目的1.确定C99/胆固醇复合体在体膜和“脂筏”中的结构。这一目标将为C99对胆固醇的分子识别提供结构基础,并将首次在模拟脂筏和整体膜的模拟膜条件下比较膜蛋白的结构。目的2.阐明胆固醇中驱动其与C99关联的结构决定因素。这将涉及C99与各种胆固醇类似物/代谢物之间的结合研究,并将进一步阐明C99与胆固醇之间的分子识别基础。它还将为开发模拟胆固醇但更能与C99结合的化合物提供一个起点。此外,我们将测试已知的“恐筏恐惧症”的胆固醇类似物能否有效地与胆固醇竞争与C99结合。目的3.确定胆固醇与C99和APP的结合是否增加了这些蛋白质在脂筏中的分配。巨大的单层囊泡和细胞衍生的囊泡都将被使用。这些研究将检验这样一种假设,即胆固醇与C99和APP的关联推动这些蛋白质分裂成木筏。此外,利用Aim 2中选择的与胆固醇有效竞争但对RAFT没有亲和力的化合物,我们还将测试是否可以抑制C99/APP的RAFT结合。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLES R SANDERS其他文献

CHARLES R SANDERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLES R SANDERS', 18)}}的其他基金

Targeting the PMP22 Protein to Develop Leads Against Charcot-Marie-Tooth Disease
靶向 PMP22 蛋白开发抗腓骨肌萎缩症的先导药物
  • 批准号:
    10331038
  • 财政年份:
    2021
  • 资助金额:
    $ 29.83万
  • 项目类别:
Cholesterol and the Amyloid Precursor Protein
胆固醇和淀粉样前体蛋白
  • 批准号:
    8529109
  • 财政年份:
    2013
  • 资助金额:
    $ 29.83万
  • 项目类别:
Cholesterol and the Amyloid Precursor Protein
胆固醇和淀粉样前体蛋白
  • 批准号:
    8642200
  • 财政年份:
    2013
  • 资助金额:
    $ 29.83万
  • 项目类别:
Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2
整合素α1β1和α2β2的结构功能分析
  • 批准号:
    9270816
  • 财政年份:
    2010
  • 资助金额:
    $ 29.83万
  • 项目类别:
Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2
整合素α1β1和α2β2的结构功能分析
  • 批准号:
    8500247
  • 财政年份:
    2010
  • 资助金额:
    $ 29.83万
  • 项目类别:
FASEB Summer Research Conference on Molecular Biophysics of Cellular Membranes
FASEB 细胞膜分子生物物理学夏季研究会议
  • 批准号:
    8004602
  • 财政年份:
    2010
  • 资助金额:
    $ 29.83万
  • 项目类别:
Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2
整合素α1β1和α2β2的结构功能分析
  • 批准号:
    8286378
  • 财政年份:
    2010
  • 资助金额:
    $ 29.83万
  • 项目类别:
Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2
整合素α1β1和α2β2的结构功能分析
  • 批准号:
    8002171
  • 财政年份:
    2010
  • 资助金额:
    $ 29.83万
  • 项目类别:
Project 3
项目3
  • 批准号:
    8151962
  • 财政年份:
    2010
  • 资助金额:
    $ 29.83万
  • 项目类别:
Structure Function Analysis of Integrins alpha1beta1 and alpha2beta2
整合素α1β1和α2β2的结构功能分析
  • 批准号:
    8097972
  • 财政年份:
    2010
  • 资助金额:
    $ 29.83万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

A Possible Association Between Insulin and Alzheimer?s Disease: Examining the Consequences of Altered Insulin Signalling on the Expression of Human Amyloid-Beta in Caenorhabditis elegans
胰岛素与阿尔茨海默氏病之间的可能关联:检查胰岛素信号改变对秀丽隐杆线虫中人类β淀粉样蛋白表达的影响
  • 批准号:
    428670
  • 财政年份:
    2019
  • 资助金额:
    $ 29.83万
  • 项目类别:
    Studentship Programs
Nitration of Amyloid beta Alzheimer 's disease
β 淀粉样蛋白的硝化 阿尔茨海默病
  • 批准号:
    316914751
  • 财政年份:
    2016
  • 资助金额:
    $ 29.83万
  • 项目类别:
    Research Grants
Effects of Latrepirdine on beta amyloid clearance, aggregation and neurodegeneration in Alzheimer�s disease
拉曲吡啶对阿尔茨海默病β淀粉样蛋白清除、聚集和神经变性的影响
  • 批准号:
    nhmrc : 1009295
  • 财政年份:
    2011
  • 资助金额:
    $ 29.83万
  • 项目类别:
    NHMRC Project Grants
An investigation of the role of brain amyloid in cognition, brain atrophy and Alzheimer s disease in Down s syndrome
脑淀粉样蛋白在唐氏综合症认知、脑萎缩和阿尔茨海默病中作用的研究
  • 批准号:
    G1002252/1
  • 财政年份:
    2011
  • 资助金额:
    $ 29.83万
  • 项目类别:
    Research Grant
DECREASED CLEARANCE OF CNS AMYLOID-? IN ALZHEIMER?S DISEASE
中枢神经系统淀粉样蛋白清除率降低?
  • 批准号:
    8361468
  • 财政年份:
    2011
  • 资助金额:
    $ 29.83万
  • 项目类别:
Studies of an early stage amyloid formation for Parkinson`s Disease casual protein.
帕金森病休闲蛋白的早期淀粉样蛋白形成的研究。
  • 批准号:
    20550083
  • 财政年份:
    2008
  • 资助金额:
    $ 29.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Chemical crosslinking of helical form of amyloid-beta for the study of Alzheimer`s disease
β-淀粉样蛋白螺旋形式的化学交联用于阿尔茨海默氏病的研究
  • 批准号:
    318045-2005
  • 财政年份:
    2005
  • 资助金额:
    $ 29.83万
  • 项目类别:
    Postgraduate Scholarships - Master's
In vivo imaging of beta-amyloid plaques in Alzheimer´s disease via positron emission tomography (PET)
通过正电子发射断层扫描 (PET) 对阿尔茨海默病中的 β-淀粉样斑块进行体内成像
  • 批准号:
    5405697
  • 财政年份:
    2003
  • 资助金额:
    $ 29.83万
  • 项目类别:
    Research Grants
Functional studies on a neuroprotective activity of the amyloid precursor protein of Alzheimer s disease.
阿尔茨海默病淀粉样前体蛋白的神经保护活性的功能研究。
  • 批准号:
    nhmrc : 145761
  • 财政年份:
    2001
  • 资助金额:
    $ 29.83万
  • 项目类别:
    NHMRC Project Grants
The neuroanatomy of Amyloid ß-Protein desposition in Alzheimer´s disease
阿尔茨海默病中淀粉样蛋白沉积的神经解剖学
  • 批准号:
    5326596
  • 财政年份:
    2001
  • 资助金额:
    $ 29.83万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了